Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study

Author:

Zhou Hongsheng1,Yin Qingsong2,Jin Jie3,Liu Ting4,Cai Zhen3,Jiang Bin5,Li Dengju6,Sun Zimin7,Li Yan8,He Yanjuan9,Ma Liping10,Gao Sujun11,Hu Jianda12,He Aili13,Du Xin14,Liu Daihong15,Zhang Xiaohong16,Ke Xiaoyan17,Zhuang Junling18,Han Yue19,Wang Xiaoqin20,Chen Yuqi21,Gordon Paul22,Yu Dong23,Zugmaier Gerhard24,Wang Jianxiang25

Affiliation:

1. Nanfang Hospital, Southern Medical University, Guangzhou, China

2. Henan Cancer Hospital, Zhengzhou, China

3. The First Affiliated Hospital, College of Medicine, Zhejiang University College of Medicine, Hangzhou, China

4. West China Hospital, Sichuan University, Chengdu, China

5. Peking University International Hospital, Beijing, China

6. Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China

7. Anhui Provincial Hospital, Hefei, China

8. The First Hospital of China Medical University, Shenyang, China

9. Xiangya Hospital Central South University, Changsha, China

10. Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

11. The First Hospital of Jilin University, Jilin, China

12. Fujian Medical University Union Hospital, Fujian, China

13. The Second Affiliated Hospital of Xian Jiaotong University, Shaanxi, China

14. Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

15. Chinese People Liberation Army General Hospital, Beijing, China

16. The Second Affiliated Hospital Zhejiang University College of Medicine, Zhejiang, China

17. Peking University Third Hospital, Beijing, China

18. Peking Union Medical College Hospital, Beijing, China

19. The First Affiliated Hospital of Soochow University, Jiangsu, China

20. Huashan Hospital Affiliated to Fudan University, Shanghai, China

21. Global Biostatistical Sciences, Amgen Inc., Thousand Oaks, CA, USA

22. Global Development, Amgen Inc., Thousand Oaks, CA, USA

23. Amgen China, Shanghai, People’s Republic of China

24. Global Development, Amgen Research (Munich) GmbH, Munich, Germany

25. Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People’s Republic of China

Funder

Amgen Inc

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3